A24463v1013 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from A24463v1013. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In A24463v1013 Today - Breaking & Trending Today

Original-Research: Defence Therapeutics Inc. (von GBC AG): BUY

Published: February 10, 2022

^ Original-Research: Defence Therapeutics Inc. - von GBC AG Einstufung von GBC AG zu Defence Therapeutics Inc. Unternehmen: Defence Therapeutics Inc. ISIN: CA24463V1013 Anlass der Studie: Research Report (Initial Coverage) Empfehlung: BUY Kursziel: 11,02 CAD (7,06 EUR) Kursziel auf Sicht von: 31...

Source: boersennews.de

Related Topics:

Julien DesrosiersCosmin FilkerDefence Therapeutics IncResearch Report Initial CoverageDefence TherapeuticsResearch ReportInitial CoverageCancer VaccinesEinen Katalog